drugset / Trial / NCT00003714

Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer

NCT00003714 ↗

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of pyrazoloacridine in treating patients who have unresectable primary or metastatic kidney cancer that has not been previously treated.

Timeline

Start
—
Primary completion
—
Completion
—

Outcome

Outcome not reported

Stopped: “Withdrawn”

Drugs

EvaluationDrugModalityDoseRoute
Subject pyrazoloacridine Small molecule — Intravenous